Viewing Study NCT02255032

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2026-02-10 @ 5:45 PM
Study NCT ID: NCT02255032
Status: COMPLETED
Last Update Posted: 2021-02-08
First Post: 2014-09-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Sponsor: Clearside Biomedical, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uveitis View
None Macular Edema View
None Uveitis, Posterior View
None Uveitis, Anterior View
None Panuveitis View
None Uveitis, Intermediate View
Keywords:

Keywords

Keyword Brief Keyword Text View
None uveitis View
None macular edema View
None UME View
None posterior uveitis View
None anterior uveitis View
None panuveitis View
None intermediate uveitis View
None noninfectious uveitis View
None triamcinolone acetonide View
None suprachoroidal space View
None injection View
None microneedle View
None intravitreal injection View
None corticosteroid View
None CME View
None choroid View
None retina View
None microinjection View
None SCS View